Professional Documents
Culture Documents
Hanna Instruments S.R.L.: Safety Data Sheet According To Regulation (EC) No. 1907/2006
Hanna Instruments S.R.L.: Safety Data Sheet According To Regulation (EC) No. 1907/2006
1
Dated 26/09/2016
EN
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 1 / 9
Code. HI771A-0
Product name. Chlorine Ultra HR Reagent A
Chemical name and synonym. POTASSIUM IODIDE
EC number. 231-659-4
CAS number. 7681-11-0
1.2. Relevant identified uses of the substance or mixture and uses advised against.
For urgent inquiries refer to. Emergency Number - International: +(1)-703-527-3887 - UK, London:
+(44)-870-8200418 - CHEMTREC 24 hours/365 days
The product is classified as hazardous pursuant to the provisions set forth in EC Regulation 1272/2008 (CLP) (and subsequent
amendments and supplements). The product thus requires a safety datasheet that complies with the provisions of EC Regulation
1907/2006 and subsequent amendments.
Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet.
Hazard labelling pursuant to EC Regulation 1272/2008 (CLP) and subsequent amendments and supplements.
Hazard pictograms:
Hazard statements:
H302 Harmful if swallowed.
H372 Causes damage to organs through prolonged or repeated exposure.
H315 Causes skin irritation.
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 2 / 9
Precautionary statements:
P260 Do not breathe dust, fume, gas, mist, vapours, spray.
P280 Wear protective gloves.
P302+P334 IF ON SKIN: Immerse in cool water / wrap in wet bandages.
P312 Call a POISON CENTER or doctor, if you feel unwell.
P362 Take off contaminated clothing.
On the basis of available data, the product does not contain any PBT or vPvB in percentage greater than 0,1%.
Contains:
POTASSIUM IODIDE
CAS. 7681-11-0 100 Acute Tox. 4 H302, STOT RE 1 H372, Skin Irrit. 2 H315
EC. 231-659-4
INDEX.
The full wording of hazard (H) phrases is given in section 16 of the sheet.
3.2. Mixtures.
4.2. Most important symptoms and effects, both acute and delayed.
For symptoms and effects caused by the contained substances, see chap. 11.
4.3. Indication of any immediate medical attention and special treatment needed.
Information not available.
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 3 / 9
POTASSIUM IODIDE
Hydrogen iodide, Potassium oxides.
Regulatory References:
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 4 / 9
POTASSIUM IODIDE
Threshold Limit Value.
Type Country TWA/8h STEL/15min
mg/m3 ppm mg/m3 ppm
TLV-ACGIH 0,01
Predicted no-effect concentration - PNEC.
Normal value in fresh water 0,007 mg/l
Normal value for fresh water sediment 0,007 mg/kg
Normal value for water, intermittent release 0,075 mg/l
Health - Derived no-effect level - DNEL / DMEL
Effects on consumers. Effects on workers
Route of exposure Acute Acute Chronic Chronic Acute local Acute Chroni Chronic
local systemic local systemic systemic c local systemic
Oral. VND 0,01
mg/kg bw/d
Inhalation. VND 0,035 VND 0,07
mg/m3 mg/m3
Skin. VND 1 VND 1
mg/kg bw/d mg/kg
bw/d
Legend:
(C) = CEILING ; INHAL = Inhalable Fraction ; RESP = Respirable Fraction ; THORA = Thoracic Fraction.
VND = hazard identified but no DNEL/PNEC available ; NEA = no exposure expected ; NPI = no hazard identified.
As the use of adequate technical equipment must always take priority over personal protective equipment, make sure that the workplace
is well aired through effective local aspiration. Personal protective equipment must be CE marked, showing that it complies with
applicable standards.
Provide an emergency shower with face and eye wash station.
Exposure levels must be kept as low as possible to avoid significant build-up in the organism. Manage personal protective equipment so
as to guarantee maximum protection (e.g. reduction in replacement times).
HAND PROTECTION
In the case of prolonged contact with the product, protect the hands with penetration-resistant work gloves (see standard EN 374).
Work glove material must be chosen according to the use process and the products that may form. Latex gloves may cause sensitivity
reactions.
SKIN PROTECTION
Wear category III professional long-sleeved overalls and safety footwear (see Directive 89/686/EEC and standard EN ISO 20344). Wash
body with soap and water after removing protective clothing.
EYE PROTECTION
Wear airtight protective goggles (see standard EN 166).
In the presence of risks of exposure to splashes or squirts during work, adequate mouth, nose and eye protection should be used to
prevent accidental absorption.
RESPIRATORY PROTECTION
Use a type P filtering facemask (see standard EN 149) or equivalent device, whose class (1, 2 or 3) and effective need, must be defined
according to the outcome of risk assessment.
ENVIRONMENTAL EXPOSURE CONTROLS.
The emissions generated by manufacturing processes, including those generated by ventilation equipment, should be checked to ensure
compliance with environmental standards.
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 5 / 9
10.1. Reactivity.
There are no particular risks of reaction with other substances in normal conditions of use.
POTASSIUM IODIDE
May decompose on exposure to air and moisture. Stable under recommended storage conditions.
POTASSIUM IODIDE
Tin/tin oxides.
POTASSIUM IODIDE
Strong reducing agents, Nickel, Strong acids, and its alloys, Steel (all types and surface treatments), Aluminum, Alkali metals, Brass,
Magnesium, Zinc, cadmium, Copper.
POTASSIUM IODIDE
Skin corrosion/irritation, Skin, rabbit, Result: Irritating to skin - Serious eye damage/eye irritation, Eyes, rabbit, Result: Irritating to eyes,
24 h, (Draize Test) - Respiratory or skin sensitisation, Prolonged or repeated exposure may cause allergic reactions in certain sensitive
individuals - Reproductive toxicity, Exposure to excessive amounts of iodine during pregnancy is capable of producing fetal
hypothyroidism, Iodine-containing drugs have been associated with fetal goiter - Additional Information, Prolonged exposure to iodides
may produce iodism in sensitive individuals. Symptoms of exposure include: skin rash, running nose, headache and irritation of the
mucous membrane. For severe cases the skin may show pimples, boils, hives, blisters and black and blue spots. Iodides are readily
EPY 9.2.8 - SDS 1003
Hanna Instruments S.R.L. Revision nr.1
Dated 26/09/2016
EN
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 6 / 9
diffused across the placenta. Neonatal deaths from respiratory distress secondary to goiter have been reported. Iodides have been
known to cause drug-induced fevers, which are usually of short duration, Liver, Irregularities, Based on Human Evidence.
ACUTE TOXICITY.
LC50 (Inhalation - vapours) of the mixture: Not classified (no significant component).
LC50 (Inhalation - mists / powders) of the mixture: Not classified (no significant component).
LD50 (Oral) of the mixture: 1000,000 mg/kg
LD50 (Dermal) of the mixture: Not classified (no significant component).
POTASSIUM IODIDE
LD50 (Oral). 1000 mg/kg Mouse
CARCINOGENICITY.
Does not meet the classification criteria for this hazard class.
REPRODUCTIVE TOXICITY.
Does not meet the classification criteria for this hazard class.
ASPIRATION HAZARD.
Does not meet the classification criteria for this hazard class.
12.1. Toxicity.
POTASSIUM IODIDE
Toxicity to daphnia and other aquatic invertebrates, EC50, Daphnia: 2,7 mg/l - 24 h.
POTASSIUM IODIDE
LC50 - for Fish. 2190 mg/l/96h Oncorhynchus mykiss
POTASSIUM IODIDE
Solubility in water. > 10000 mg/l
Rapidly biodegradable.
POTASSIUM IODIDE
Partition coefficient: n-octanol/water. -0,958
BCF. 2,268
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 7 / 9
On the basis of available data, the product does not contain any PBT or vPvB in percentage greater than 0,1%.
14.1. UN number.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
14.7. Transport in bulk according to Annex II of Marpol and the IBC Code.
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture.
Restrictions relating to the product or contained substances pursuant to Annex XVII to EC Regulation 1907/2006.
None.
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 8 / 9
Healthcare controls.
Workers exposed to this chemical agent must not undergo health checks, provided that available risk-assessment data prove that the
risks related to the workers' health and safety are modest and that the 98/24/EC directive is respected.
No chemical safety assessment has been processed for the mixture and the substances it contains.
LEGEND:
- ADR: European Agreement concerning the carriage of Dangerous goods by Road
- CAS NUMBER: Chemical Abstract Service Number
- CE50: Effective concentration (required to induce a 50% effect)
- CE NUMBER: Identifier in ESIS (European archive of existing substances)
- CLP: EC Regulation 1272/2008
- DNEL: Derived No Effect Level
- EmS: Emergency Schedule
- GHS: Globally Harmonized System of classification and labeling of chemicals
- IATA DGR: International Air Transport Association Dangerous Goods Regulation
- IC50: Immobilization Concentration 50%
- IMDG: International Maritime Code for dangerous goods
- IMO: International Maritime Organization
- INDEX NUMBER: Identifier in Annex VI of CLP
- LC50: Lethal Concentration 50%
- LD50: Lethal dose 50%
- OEL: Occupational Exposure Level
- PBT: Persistent bioaccumulative and toxic as REACH Regulation
- PEC: Predicted environmental Concentration
- PEL: Predicted exposure level
- PNEC: Predicted no effect concentration
- REACH: EC Regulation 1907/2006
- RID: Regulation concerning the international transport of dangerous goods by train
- TLV: Threshold Limit Value
- TLV CEILING: Concentration that should not be exceeded during any time of occupational exposure.
Printed on 13/10/2016
HI771A-0 - Chlorine Ultra HR Reagent A Page n. 9 / 9
GENERAL BIBLIOGRAPHY
1. Regulation (EU) 1907/2006 (REACH) of the European Parliament
2. Regulation (EU) 1272/2008 (CLP) of the European Parliament
3. Regulation (EU) 790/2009 (I Atp. CLP) of the European Parliament
4. Regulation (EU) 2015/830 of the European Parliament
5. Regulation (EU) 286/2011 (II Atp. CLP) of the European Parliament
6. Regulation (EU) 618/2012 (III Atp. CLP) of the European Parliament
7. Regulation (EU) 487/2013 (IV Atp. CLP) of the European Parliament
8. Regulation (EU) 944/2013 (V Atp. CLP) of the European Parliament
9. Regulation (EU) 605/2014 (VI Atp. CLP) of the European Parliament